Verdence Capital Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.67M Sell
15,021
-5,191
-26% -$576K 0.11% 184
2025
Q1
$2.26M Sell
20,212
-4,514
-18% -$506K 0.17% 128
2024
Q4
$2.28M Sell
24,726
-1,973
-7% -$182K 0.18% 133
2024
Q3
$2.24M Buy
26,699
+3,261
+14% +$273K 0.18% 148
2024
Q2
$1.61M Buy
23,438
+2,929
+14% +$201K 0.14% 177
2024
Q1
$1.5M Buy
20,509
+7,249
+55% +$531K 0.14% 185
2023
Q4
$1.07M Sell
13,260
-166
-1% -$13.4K 0.1% 208
2023
Q3
$1.01M Buy
13,426
+2,069
+18% +$155K 0.11% 208
2023
Q2
$875K Sell
11,357
-4,227
-27% -$326K 0.1% 216
2023
Q1
$1.29M Sell
15,584
-9,346
-37% -$775K 0.16% 158
2022
Q4
$2.14M Sell
24,930
-3,732
-13% -$320K 0.26% 93
2022
Q3
$1.77M Buy
28,662
+1,505
+6% +$92.8K 0.24% 109
2022
Q2
$1.68M Buy
27,157
+525
+2% +$32.5K 0.22% 118
2022
Q1
$1.58M Buy
26,632
+5,354
+25% +$318K 0.18% 130
2021
Q4
$1.55M Buy
21,278
+700
+3% +$50.8K 0.18% 126
2021
Q3
$1.44M Buy
20,578
+493
+2% +$34.4K 0.19% 128
2021
Q2
$1.38M Buy
20,085
+2,406
+14% +$166K 0.19% 122
2021
Q1
$1.14M Buy
17,679
+11,152
+171% +$721K 0.19% 131
2020
Q4
$380K Sell
6,527
-5,805
-47% -$338K 0.07% 248
2020
Q3
$779K Buy
12,332
+6,758
+121% +$427K 0.18% 136
2020
Q2
$429K Sell
5,574
-9,180
-62% -$707K 0.11% 201
2020
Q1
$1.1M Buy
14,754
+1,473
+11% +$110K 0.33% 84
2019
Q4
$863K Sell
13,281
-695
-5% -$45.2K 0.21% 116
2019
Q3
$886K Buy
+13,976
New +$886K 0.25% 118
2018
Q2
Sell
-4,674
Closed -$352K 298
2018
Q1
$352K Sell
4,674
-3,451
-42% -$260K 0.08% 200
2017
Q4
$582K Buy
+8,125
New +$582K 0.14% 135